特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

陰圧創傷治療装置の欧州市場予測:2019-2028年

Europe Negative Pressure Wound Therapy Devices Market Forecast 2019-2028

発行 Inkwood Research 商品コード 950347
出版日 ページ情報 英文 142 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.57円で換算しております。
陰圧創傷治療装置の欧州市場予測:2019-2028年 Europe Negative Pressure Wound Therapy Devices Market Forecast 2019-2028
出版日: 2020年07月20日 ページ情報: 英文 142 Pages
概要

欧州の陰圧創傷治療 (NPWT) 装置市場は、2019年から2028年の予測期間中、5.22%のCAGRで成長すると予測されています。市場の成長を促進する要因として、糖尿病の有病率の上昇、高齢者人口の増加、および手術数の増加が挙げられます。

当レポートでは、陰圧創傷治療 (NPWT) 装置の欧州市場について調査し、市場の概要、市場成長への主な影響要因の分析、各セグメント・地域別の分析と予測、および主要企業のプロファイルなどを提供しています。

第1章 調査範囲と調査手法

  • 調査目的
  • 調査範囲
  • 調査手法
  • 前提条件と制限事項

第2章 エグゼクティブサマリー

  • 市場規模・推計
  • 市場概要

第3章 市場力学

  • 親市場の分析:医療機器市場
  • 市場の定義
  • 主な促進要因
    • 技術革新
    • 高齢者人口の増加
    • ヘルスケア治療におけるコスト削減の要件
    • 慢性創傷に対する懸念の高まり
    • 糖尿病の症例数の増加
  • 主な抑制要因
    • 高コスト
    • NPWT装置の使用に関連する問題
    • 訓練を受けた専門家の不足

第4章 主な分析

  • 主な投資の考察
  • ポーターのファイブフォース分析
  • 市場機会マトリクス
  • ベンダー情勢
  • COVID-19の影響

第5章 市場:製品別

  • 従来型の再利用可能装置
  • 使い捨て装置

第6章 市場:エンドユーザー別

  • 病院&クリニック
  • 外来手術センター(ASC)
  • 在宅医療

第7章 市場:創傷タイプ別

  • 慢性創傷
    • 圧迫潰瘍
    • 糖尿病性足潰瘍
    • 静脈うっ滞性下腿潰瘍/静脈性下腿潰瘍(VLU)
    • 動脈性潰瘍
  • 急性創傷
    • 熱傷&外傷
    • 外科的創傷

第8章 地域分析

  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • ロシア
    • ベルギー
    • ポーランド
    • その他欧州

第9章 企業プロファイル

  • 3M COMPANY
  • CARDINAL HEALTH
  • DEROYAL INDUSTRIES INC
  • SMITH & NEPHEW PLC
  • PAUL HARTMANN AG
  • TALLEY GROUP LIMITED
  • DEVON INTERNATIONAL GROUP INC
  • MOLNLYCKE HEALTH CARE AB
  • MEDELA AG
  • CONVATEC GROUP PLC
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - NEGATIVE PRESSURE WOUND THERAPY DEVICES
  • TABLE 2: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY WOUND TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY WOUND TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: EUROPE CHRONIC WOUNDS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: EUROPE CHRONIC WOUNDS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 10: EUROPE ACUTE WOUNDS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: EUROPE ACUTE WOUNDS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 12: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019
  • FIGURE 6: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY CONVENTIONAL REUSABLE DEVICES, 2019-2028 (IN $ MILLION)
  • FIGURE 7 EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY SINGLE USE DEVICES, 2019-2028 (IN $ MILLION)
  • FIGURE 8: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019
  • FIGURE 9: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY HOSPITALS & CLINICS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY AMBULATORY SURGICAL CENTERS, 2019-2028 (IN $ MILLION)
  • FIGURE 11: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY HOME CARE SETTINGS, 2019-2028 (IN $ MILLION)
  • FIGURE 12: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, GROWTH POTENTIAL, BY WOUND TYPE, IN 2019
  • FIGURE 13: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY CHRONIC WOUNDS, 2019-2028 (IN $ MILLION)
  • FIGURE 14: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY PRESSURE ULCER, 2019-2028 (IN $ MILLION)
  • FIGURE 15: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY DIABETIC FOOT ULCER, 2019-2028 (IN $ MILLION)
  • FIGURE 16: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY VENOUS LEG ULCER, 2019-2028 (IN $ MILLION)
  • FIGURE 17: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY ARTERIAL ULCER, 2019-2028 (IN $ MILLION)
  • FIGURE 18: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY ACUTE WOUNDS, 2019-2028 (IN $ MILLION)
  • FIGURE 19: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY BURNS & TRAUMA, 2019-2028 (IN $ MILLION)
  • FIGURE 20: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY SURGICAL WOUNDS, 2019-2028 (IN $ MILLION)
  • FIGURE 21: EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 22: UNITED KINGDOM NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GERMANY NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 24: FRANCE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 25: ITALY NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 26: RUSSIA NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 27: BELGIUM NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 28: POLAND NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 29: REST OF EUROPE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, 2019-2028 (IN $ MILLION)
目次
Product Code: 32711

KEY FINDINGS

The Europe negative pressure wound therapy devices market is predicted to grow with a CAGR of 5.22%, during the forecast years of 2019 to 2028. The major factors fuelling the market growth include the rise in diabetes prevalence, the growing geriatric population, and an increase in the number of surgeries.

MARKET INSIGHTS

The Europe negative pressure wound therapy devices market growth is assessed across Belgium, Russia, the United Kingdom, Poland, France, Germany, Italy, and the rest of the world. In France, the awareness regarding healthcare benefits has encouraged residents to consider surgical alternatives. The demand for negative pressure wound therapy devices is considerably growing in the country, as surgical wounds can be easily treated using them. Thus, the rising number of medical operations is projected to drive the market growth in France. Additionally, more people are choosing advanced wound therapies, as the French healthcare reimburses nearly 80% of the patient's total expense during surgeries.

The International Federation for Diabetes attested that the prevalence of diabetes in France is more than 7%, and the total cases recorded in 2017 accounted for over 3,270,000. The high incidence of diabetes in the country leads to a rise in diabetes-related ulcers and wounds among patients. As a result, the increase in patients with diabetes is estimated to propel the market growth for negative pressure wound therapy devices.

COMPETITIVE INSIGHTS

Prominent players in the market include Talley Group Limited, Molnlycke Health Care AB, Deroyal Industries Inc, Devon International Group Inc, Medela AG, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES `
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. PARENT MARKET ANALYSIS: MEDICAL DEVICES MARKET
  • 3.2. MARKET DEFINITION
  • 3.3. KEY DRIVERS
    • 3.3.1. INNOVATION IN TECHNOLOGY
    • 3.3.2. RISE IN GERIATRIC POPULATION
    • 3.3.3. REQUIREMENT OF COST REDUCTION IN HEALTHCARE TREATMENTS
    • 3.3.4. GROWING CONCERN OVER CHRONIC WOUNDS
    • 3.3.5. RISE IN THE NUMBER OF DIABETES CASES
  • 3.4. KEY RESTRAINTS
    • 3.4.1. HIGH COST
    • 3.4.2. COMPLICATIONS RELATED TO USE OF NPWT DEVICES
    • 3.4.3. LACK OF TRAINED PROFESSIONALS

4. KEY ANALYTICS

  • 4.1. KEY INVESTMENT INSIGHTS
  • 4.2. PORTER'S FIVE FORCE ANALYSIS
    • 4.2.1. BUYER POWER
    • 4.2.2. SUPPLIER POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. IMPACT OF COVID-19

5. MARKET BY PRODUCT

  • 5.1. CONVENTIONAL REUSABLE DEVICES
  • 5.2. SINGLE USE DEVICES

6. MARKET BY END-USER

  • 6.1. HOSPITALS & CLINICS
  • 6.2. AMBULATORY SURGICAL CENTERS
  • 6.3. HOME CARE SETTINGS

7. MARKET BY WOUND TYPE

  • 7.1. CHRONIC WOUNDS
    • 7.1.1. PRESSURE ULCER
    • 7.1.2. DIABETIC FOOT ULCER
    • 7.1.3. VENOUS LEG ULCER
    • 7.1.4. ARTERIAL ULCER
  • 7.2. ACUTE WOUNDS
    • 7.2.1. BURNS & TRAUMA
    • 7.2.2. SURGICAL WOUNDS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. EUROPE
    • 8.1.1. UNITED KINGDOM
    • 8.1.2. GERMANY
    • 8.1.3. FRANCE
    • 8.1.4. ITALY
    • 8.1.5. RUSSIA
    • 8.1.6. BELGIUM
    • 8.1.7. POLAND
    • 8.1.8. REST OF EUROPE

9. COMPANY PROFILES

  • 9.1. 3M COMPANY
  • 9.2. CARDINAL HEALTH
  • 9.3. DEROYAL INDUSTRIES INC
  • 9.4. SMITH & NEPHEW PLC
  • 9.5. PAUL HARTMANN AG
  • 9.6. TALLEY GROUP LIMITED
  • 9.7. DEVON INTERNATIONAL GROUP INC
  • 9.8. MOLNLYCKE HEALTH CARE AB
  • 9.9. MEDELA AG
  • 9.10. CONVATEC GROUP PLC